Anlon Healthcare Limited is a growing pharmaceutical company. it is gearing up to launch its Initial Public Offering (IPO). This company known for ingredients for medicines, the company has been a hot topic among investors. Here is a simple overview of the IPO dates, price and other important details.
When Is the IPO Happening?
The Anlon Healthcare IPO will open for subscription on August 26, 2025, and it close on August 29, 2025. The IPO Share allotments are expected to be finalised on September 1, 2025, and the shares will likely list on the BSE and NSE on September 3, 2025. The IPO aims to raise around Rs 121.03 crore by issuing 1.33 crore new shares, with a face value of Rs 10 each.
Anlon Healthcare IPO Price and Application Details
The Anlon Healthcare IPO’s price range is set at ₹86 to ₹91 per share. Retail investors can apply for a minimum of 164 shares (one lot), which costs ₹14,104 at the lower price. For small Non-Institutional Investors (sNII), the minimum is 14 lots (2,296 shares), costing ₹208,936 at the upper price. Big Non-Institutional Investors (bNII) need 68 lots (11,152 shares), which amounts to ₹1,014,832 at the top price.
About Anlon Healthcare
Anlon Healthcare Ltd was Started in 2013 in Rajkot, Gujarat, Anlon Healthcare makes high-purity ingredients for medicines, nutraceuticals, personal care, and animal health products. It’s one of the few companies in India producing loxoprofen sodium dihydrate, used for pain relief. As of January 2025, the company had 105 employees, 65 active products, and several more in development. Its promoters are Punitkumar R. Rasadia, Meet Atulkumar Vachhani, and Mamata Punitkumar Rasadia.
Anlon Healthcare IPO Financial Snapshot
Anlon Healthcare’s financials show promise. In 2024, the company earned ₹66.69 crores in revenue, down from ₹113.12 crores in 2023. However, its profit after tax jumped by 112% to ₹9.66 crores in 2024 from ₹5.82 crores in 2023. This growth makes the IPO appealing to investors looking for long-term gains.
Anlon Healthcare IPO Grey Market Premium (GMP)
The Grey Market Premium (GMP) for this IPO isn’t available yet, as it usually starts closer to the opening date. The IPO GMP can hint at the expected listing price, but it’s not a sure bet, so investors should be cautious.
How to Apply for Anlon Healthcare IPO
Anlon Healthcare IPO application is easy. Investors can use ASBA (Application Supported by Blocked Amount) via UPI through their bank or broker. For example, Zerodha users can log in to their account, go to the IPO section, select Anlon Healthcare IPO and apply. It is a simple process for retail investors.
Anlon Healthcare IPO Allotment and Listing Process
According to the report, the share allotment should be completed by September 1, 2025 and the shares should be credited to the demat accounts by September 2, 2025. Investors can check their allotment status on the website of the registrar, KFin Technologies Ltd, using their PAN, application number or DP client ID. The shares are scheduled to be listed on BSE and NSE on September 3, 2025.
Should You Invest?
Anlon Healthcare’s strengths include its diverse products, experienced team, and certifications like ISO 9001:2015 and WHO-GMP. Its export business and focus on specialized products add to its appeal. However, relying on a single manufacturing unit in Rajkot could be a risk. Experts suggest this IPO suits investors with a long-term view, given the company’s growth and industry position.
Final Thoughts
The Anlon Healthcare IPO is a chance to invest in a promising pharmaceutical player. With the subscription window opening soon, investors should read the company’s Red Herring Prospectus (RHP) and consult financial advisors before applying. Keep an eye out for updates on GMP and subscription trends as the IPO nears.
Leave a Reply